Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
• Kodiak Gas Services Inc (KGS) PT Raised to $90 at Stifel on Multi-Year Growth Potential